Asselah, T., Thompson, A. J., Flisiak, R., Romero Gómez, M., Messinger, D., Bakalos, G., & Shiffman, M. L. (2016). A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.
Citación estilo ChicagoAsselah, Tarik, Ale J. Thompson, Robert Flisiak, Manuel Romero Gómez, Diethelm Messinger, Georgios Bakalos, y Mitchell L. Shiffman. A Predictive Model for Selecting Patients With HCV Genotype 3 Chronic Infection With a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. 2016.
Cita MLAAsselah, Tarik, et al. A Predictive Model for Selecting Patients With HCV Genotype 3 Chronic Infection With a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. 2016.